Every portfolio company from acquisition through value creation to exit.
Stages for 3 of 3 holdings are inferred from relationship type and dates, not analyst-recorded.
| Company | Industry | Entry | Stage | Hold | Entry value |
|---|---|---|---|---|---|
| CBAM Partners Acquirer of Company | — | 2022 | Value creation | 4y | — |
| Abacus Pharmaceuticals Portfolio Company (Current) | — | 2018 | Exit ready | 7.9y | — |
| AlpInvest Partners Acquirer of Company | — | 2011 | Exit ready | 14.9y | — |